DRN PHARMA
DRN PHARMA is a Turkish pharmaceutical export and distribution company operating from Istanbul with a 6,961-product catalog, serving international health ministries, healthcare organizations, and humanitarian aid groups across 23+ countries through direct export, parallel export, licensing, and tender participation.
- Company typePrivate
- Founded2018
- HeadquartersEsenler
- Headcount11–50
- GTM typeB2B
- OfferingServices
What DRN PHARMA does
DRN PHARMA is a privately held Turkish pharmaceutical export and distribution company headquartered in Esenler, Istanbul, operating under Turkey's Law No. 1262 governing pharmaceutical and medical product sales. The company runs a B2B export business with a catalog of 6,961 pharmaceutical products sourced from manufacturers in 14+ countries spanning therapeutic categories such as cardiovascular, oncology, anti-infectives, and diabetes. Its core customers are international healthcare organizations, foreign health ministries, hospitals, pharmacies, and humanitarian aid associations, with active export relationships across 23+ countries and a customer base of 150+ active accounts. Annual export volume exceeds 75,000 units and current stock includes 8,000+ items.
The company monetizes through multiple channels: direct export with official export declarations, parallel export of products unavailable in destination markets, registration and licensing of domestically manufactured products for foreign markets, participation in international Ministry of Health tenders, and supply to international health organizations. Distribution is supported by multi-modal logistics — road, air, sea, courier, and specialized cold chain — backed by a 30 m2 cold storage facility with 24-hour temperature-humidity monitoring and calibrated recording devices. Operationally, all warehouse intake passes through the Turkish medication tracking system (İlaç Takip Sistemi), and the company's automation system controls product acceptance, storage, and dispatch under a Ministry of Health-approved and inspected quality assurance system.
The business operates with 11-50 employees and appears independently owned with no disclosed institutional investors, funding rounds, or M&A activity. Digital presence includes a multi-language website (Turkish, English, Arabic, Chinese) with online chat and WeChat contact channels targeting international buyers. Pricing is quote-based and not publicly disclosed, consistent with B2B pharmaceutical trading where margins are negotiated per transaction or tender. No management team, ownership structure, patents, awards, or formal partnership agreements are publicly disclosed.
DRN PHARMA firmographics
Firmographics- Name
- DRN PHARMA
- Legal name
- DRN Pharma
- Website
- https://drnpharma.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- DRN PHARMA is a Turkish pharmaceutical export and distribution company operating from Istanbul with a 6,961-product catalog, serving international health ministries, healthcare organizations, and humanitarian aid groups across 23+ countries through direct export, parallel export, licensing, and tender participation.
- Ownership category
- akta.pro rank
DRN PHARMA industry classification
Industry- Product category
- Pharmaceutical Wholesale Distribution & Export
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)
- akta.pro secondary industries
- Pharmaceutical & Biopharma Cold Chain Logistics (2–8°C, CRT, GDP) (TLAIAIAA), Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)
Keywords
Where DRN PHARMA is headquartered
LocationHeadquarters
- HQ city
- Esenler
Offices1 record
Markets served
DRN PHARMA business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Pharmaceutical Export Sales: Direct export of pharmaceutical and medical material products to international markets with official export declarations, serving healthcare organizations, government tender systems, and parallel import/export needs.
- Parallel Export: Supply of healthcare products not available domestically, sourced from other countries and sold to other nations either directly or indirectly.
- Licensing/Registration Services: Registration and sale of domestically manufactured products to foreign markets through licensing arrangements.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels2 records
DRN PHARMA product offering
Product offeringCore offering
DRN PHARMA is a Turkey-based pharmaceutical export and distribution company that sells a catalog of 6,961 pharmaceutical and medical material products to international markets through official export declarations, parallel export, registration/licensing, international Ministry of Health tenders, and direct supply to international health organizations and humanitarian aid associations. The company is supported by a Ministry of Health-approved quality assurance system, an integrated medication tracking system, warehouse automation, 24/7 temperature and humidity monitoring, and a 30 m² cold storage facility enabling end-to-end cold chain logistics for temperature-sensitive medications.
Product overview
DRN PHARMA is a pharmaceutical export and distribution company operating under Law No. 1262 regarding the sale of pharmaceutical and medical products. The company operates as a B2B pharmaceutical distributor with a quality assurance system approved and inspected by the Ministry of Health. The core offering consists of a product catalog containing 6,961 pharmaceutical products from various Turkish and international manufacturers, supported by export services (including parallel export, registration services, tender participation, and health organization supply), humanitarian assistance programs, and cold chain logistics infrastructure. The company serves over 150 active customers across 23+ countries with an annual export volume exceeding 75,000 products.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical Products Catalog (6,961 products) A comprehensive catalog of 6,961 pharmaceutical and medical material products spanning therapeutic categories such as cardiovascular disease, diabetes, oncology, and anti-infectives, sourced from manufacturers in Turkey, Japan, Germany, Denmark, USA, France, Ireland, Switzerland, Greece, Saudi Arabia, Spain, Italy, Norway, Canada, and Puerto Rico. Offered to international B2B buyers via export declarations.
- Export Services Sale of all products under medication and medical materials category to another country with an official export declaration in accordance with approval from the relevant ministry. Intended for international healthcare buyers.
- Parallel Export Services Supply of all healthcare products not available domestically from another country, then sold to another country directly or indirectly. Serves buyers seeking medicines unavailable in their home market.
- Registration/Licensing Services Registration and sale of products manufactured domestically in another country, handling regulatory licensing for international markets. Targeted at pharmaceutical manufacturers seeking entry into foreign markets and at international buyers needing licensed supply.
- Tender Participation Services Product sale through international tenders of Ministry of Health, participating in government procurement processes for pharmaceutical supplies. Targeted at government health ministries and procurement agencies.
- Health Organization Supply Services Product sale to international health organizations including WHO and other global health entities. Targeted at global and regional public health agencies.
- Humanitarian Assistance Program Provision of medications to patients in need through humanitarian assistance associations in international and domestic projects, ensuring medicine access regardless of conditions. Targeted at humanitarian aid associations.
- Cold Chain Storage and Shipping Professional 30 m² cold storage facility for temperature-sensitive products, monitored 24 hours with temperature-humidity recording devices, with cold chain products transported using approved and calibrated temperature recording devices. Targeted at international B2B buyers requiring temperature-sensitive pharmaceutical logistics.
- Multi-Modal Shipping Services Shipping services including highway dispatch, airway shipment, sea shipment, courier shipment, cold chain shipment, and multimodal shipping options. Targeted at international B2B buyers across 23+ countries.
Companies that use DRN PHARMA
Customer profileSegments2 records
Ideal customer profiles2 records
DRN PHARMA technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
DRN PHARMA partnerships and signals
Strategic signalScale indicators5 records
Recent moves5 records
Expansion highlights4 records
DRN PHARMA competitors and assessment
Company assessmentBroad incumbents
- McKesson Corporation: Largest North American pharmaceutical wholesaler and distributor with global reach across branded, specialty, and generic pharmaceuticals. Comparable to DRN Pharma as a multi-country pharma distribution operator, though vastly larger and serving a broader customer base (retail pharmacies, hospitals, governments).
- Cencora (formerly AmerisourceBergen): Top-tier global pharmaceutical distribution and specialty services company operating across North America, Europe, and emerging markets. Peer to DRN Pharma in the cross-border pharmaceutical distribution and government/pharma services space, but at materially larger scale with integrated consulting and biopharma services.
- Cardinal Health: Major US-headquartered pharmaceutical and medical products distributor serving retail, hospital, and government customers globally. Comparable to DRN Pharma as a wholesale pharma distribution and government-health-supply operator, with a much wider product portfolio and deeper cold-chain infrastructure.
- DHL Supply Chain – Life Sciences & Healthcare: Global 3PL with a dedicated life-sciences vertical handling pharma distribution, cold-chain transport, and GDP-compliant storage. Comparable to DRN Pharma's multi-modal (road/air/sea/courier) pharmaceutical logistics model, but at substantially larger scale and broader service scope.
- Kuehne+Nagel – Life Sciences & Healthcare: One of the world's largest freight forwarders with a dedicated KN PharmaChain and Life Sciences Logistics product covering GDP-compliant cold-chain road, air, and sea services. Comparable to DRN Pharma's GDP/cold-chain positioning and multi-modal shipping capability, but as a global incumbent with deeper temperature-controlled capacity.
Direct peers
- Phoenix Group: Leading European pharmaceutical wholesale distributor (Phoenix Group, headquartered in Germany) operating in 27+ European countries with integrated pharmacy retail. Closest direct comparable to DRN Pharma in cross-border wholesale pharma distribution and parallel-trade activities serving pharmacies, hospitals, and ministry buyers.
- World Courier (Cencora): Specialty logistics provider focused on time-sensitive and temperature-controlled pharmaceutical shipments, including clinical trial materials and biologics. Direct peer to DRN Pharma's cold-chain export capability and therapeutic-area-driven distribution model, with global but specialty-aligned footprint.
Emerging players
- Quick Healthcare Logistics / Yourway: Niche specialty logistics provider for clinical trial materials, investigational products, and temperature-sensitive pharmaceuticals with global reach. Emerging-player peer to DRN Pharma's cold-chain and international pharma delivery proposition, with stronger clinical-trial orientation.
Regional players
- Imperial Health Sciences: Specialized pharmaceutical distributor serving sub-Saharan African markets with cold-chain warehousing, tender participation, and GDP-compliant operations. Comparable to DRN Pharma as a regional pharma wholesaler serving government/MoH tender flow with cold-chain capability, but geographically focused on Africa rather than Turkey/Eurasia.
Others
- Sanovel İlaç: Major Turkish pharmaceutical manufacturer with growing international registration activity. Adjacent/ecosystem player to DRN Pharma, representing the type of domestic Turkish pharma producer whose products DRN registers and exports abroad.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
DRN PHARMA social profiles
Digital presenceDRN PHARMA financial estimates
Financial estimateRevenue estimate
Valuation estimate
DRN PHARMA leadership team
Management profileNumber of profiles
DRN PHARMA funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DRN PHARMA M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DRN PHARMA
What does DRN PHARMA do?
DRN PHARMA is a Turkey-based pharmaceutical export and distribution company that sells a catalog of 6,961 pharmaceutical and medical material products to international markets through official export declarations, parallel export, registration/licensing, international Ministry of Health tenders, and direct supply to international health organizations and humanitarian aid associations. The company is supported by a Ministry of Health-approved quality assurance system, an integrated medication tracking system, warehouse automation, 24/7 temperature and humidity monitoring, and a 30 m² cold storage facility enabling end-to-end cold chain logistics for temperature-sensitive medications.
Is DRN PHARMA a public or private company?
DRN PHARMA is a private company. It is classified as unknown and is currently operating.
When was DRN PHARMA founded?
DRN PHARMA was founded in 2018. It employs 11 to 50 people.
Where is DRN PHARMA based?
DRN PHARMA is headquartered in Esenler.
How does DRN PHARMA make money?
Three revenue lines are on record. Pharmaceutical Export Sales are the primary driver. The others are parallel Export and licensing/Registration Services.
Who are DRN PHARMA's main competitors?
Broad incumbents on record are McKesson Corporation, Cencora (formerly AmerisourceBergen), Cardinal Health, DHL Supply Chain – Life Sciences & Healthcare and Kuehne+Nagel – Life Sciences & Healthcare. Direct peers are Phoenix Group and World Courier (Cencora). Quick Healthcare Logistics / Yourway is listed as an emerging player. Imperial Health Sciences is listed as a regional player. Sanovel İlaç is listed as an others.
Does DRN PHARMA have an API?
No public API is recorded for DRN PHARMA.
What industry is DRN PHARMA in?
DRN PHARMA's product category is Pharmaceutical Wholesale Distribution & Export. Its primary akta.pro industry code is CRAOAHAA, Prescription Pharmaceutical (Rx) Wholesale Distribution, with a secondary code of TLAIAIAA, Pharmaceutical & Biopharma Cold Chain Logistics (2–8°C, CRT, GDP). Its NAICS code is 424210 and its SIC code is 5122.